Symposium on live biotherapeutic products, held in Amsterdam on April 29–30, 2025. Igor Mierau, Director of Genetic Engineering and Manufacturing, participated as a Key Speaker.
Share the event:
Aurealis Therapeutics CEO, Juha Yrjänheikki, and COO, Laurent Décory, will be attending the Biotech Week Boston from 15-18 September 2025 in Boston, USA.
Aurealis Therapeutics team visited China from June 9–13, 2025, for a dedicated partnering week. Juha Yrjänheikki (CEO), Laurent Décory (COO), Hanna-Riikka Kärkkäinen (Director, Quality & Regulatory Affairs), and Jere Kurkipuro (Director, Pre-clinical & Pharmacology) met with investors, scientific partners, and licensing stakeholders to explore new collaboration opportunities.
Baarerstrasse 21, CH-6300
Zug, Switzerland
Microkatu 1, FI-70210
Kuopio, Finland
This information will only be used to send you our newsletter. You can unsubscribe at any moment.
Ⓒ 2025 Aurealis Therapeutics. All Rights Reserved.